Dysplastic Nevi

In a top Healio Dermatology story, preliminary findings from Emma Guttman-Yassky, MD, PhD, demonstrate a novel use of dupilumab for managing chronic keloids with reductions in skin fibrosis and keloidal scarring, which may suggest a potential underlying Th2 pathogenesis in keloid formation.

How clinicians frame the information presented to patients about dysplastic nevi diagnosis and management affects patient decision-making on surgical options, according to researchers in Journal of the American Academy of Dermatology.